Related Experiment Videos
Mesenteric vasoconstriction in cardiogenic shock in pigs.
P M Reilly1, S MacGowan, M Miyachi
1Department of Surgery, Johns Hopkins Medical Institutions, Baltimore, Maryland.
Gastroenterology
|June 1, 1992
Summary
Mesenteric vasoconstriction significantly impacts cardiogenic shock by increasing systemic vascular resistance. Angiotensin II blockade prevents this response, highlighting its critical role in shock hemodynamics.
Area of Science:
- Cardiovascular Physiology
- Hemodynamics
- Shock Pathophysiology
Background:
- Cardiogenic shock, often caused by pericardial tamponade, severely impairs systemic circulation.
- The role of mesenteric vasoconstriction in the overall hemodynamic response to shock is not fully understood.
Purpose of the Study:
- To quantify the impact of mesenteric vasoconstriction on systemic hemodynamics during cardiogenic shock.
- To identify the specific vasoactive systems mediating mesenteric vasoconstriction in this condition.
Main Methods:
- Inducing graded pericardial tamponade in an experimental model.
- Measuring cardiac output, arterial pressure, and regional vascular resistance (mesenteric and non-mesenteric).
- Evaluating the effects of blocking the renin-angiotensin, alpha-adrenergic, and vasopressin systems; infusing vasoactive agents.
Main Results:
- Pericardial pressure elevation reduced cardiac output and arterial pressure, while increasing total peripheral resistance.
- Mesenteric vascular resistance increased disproportionately (223%), accounting for 42% of the total increase in systemic vascular resistance.
- Blockade of the renin-angiotensin axis abolished the mesenteric vasoconstriction; alpha-adrenergic or vasopressin blockade had no effect.
- Angiotensin II infusion mimicked the selective mesenteric vasoconstriction.
Conclusions:
- Angiotensin II-mediated mesenteric vasoconstriction is a major contributor (over 40%) to increased systemic vascular resistance in cardiogenic shock.
- Targeting the renin-angiotensin system may be a therapeutic strategy for managing cardiogenic shock.